G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,522 | -16.6% | 12,135 | +137.1% | 0.00% | – |
| Q1 2022 | $39,000 | -25.0% | 5,118 | 0.0% | 0.00% | – |
| Q4 2021 | $52,000 | -24.6% | 5,118 | 0.0% | 0.00% | – |
| Q3 2021 | $69,000 | -38.4% | 5,118 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $112,000 | -8.9% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | +33.7% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $92,000 | +178.8% | 5,118 | +80.2% | 0.00% | – |
| Q3 2020 | $33,000 | -52.2% | 2,840 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $69,000 | +475.0% | 2,840 | +158.4% | 0.00% | – |
| Q1 2020 | $12,000 | -58.6% | 1,099 | 0.0% | 0.00% | – |
| Q4 2019 | $29,000 | +16.0% | 1,099 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -26.5% | 1,099 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +88.9% | 1,099 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -14.3% | 1,099 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -12.5% | 1,099 | +134.8% | 0.00% | – |
| Q3 2018 | $24,000 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |